Get Permission

As of the ONS Annual Congress, three patients at Memorial Sloan-Kettering Cancer Center had been successfully treated in the outpatient setting with genetically modified T cell therapy, without major events or readmissions to the hospital, reported study author Cheryl Caravano, RN. Ms. Caravano hopes that her study will serve as a model for oncology nurses involved in using T-cell treatment for CLL.

Related Articles

Genetically Modified T-cell Therapy for Patients with CLL: The Role of the Oncology Nurse

Quality nursing and ongoing education are critical for success in using gene-modified T-cell therapy for patients with chronic lymphocytic leukemia (CLL), said Cheryl Caravano, RN, at the recent Annual Congress of the Oncology Nursing Society.  Ms. Caravano is a clinical nurse IV at Memorial...




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.